ChemicalBook--->CAS DataBase List--->849217-64-7

849217-64-7

849217-64-7 Structure

849217-64-7 Structure
IdentificationBack Directory
[Name]

Foretinib (GSK1363089)
[CAS]

849217-64-7
[Synonyms]

XL880
GSK089
Foretinib
EXEL-2880
GSK 1363089
EXEL-2880/XL-880
XL-880,Foretinib
Foretinib, >=98%
XL880(GSK1363089)
Foretinib (XL-880)
Foretinib, Free Base
GSK1363089/foretinib
Foretinib (GSK1363089)
Foretinib (GSK1363089, XL880)
N-(3-Fluoro-4-((6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yl)-oxy)phenyl)-N-(4-fluorophenyl)
N-(3-Fluoro-4-((6-methoxy-7-(3-morpholinopropoxy)quinolin-4-yl)-oxy)phenyl)-N-(4-fluorophenyl)cyc
N-(3-fluoro-4-(6-Methoxy-7-(3-Morpholinopropoxy)quinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxaMide
N1'-[3-fluoro-4-[[6-Methoxy-7-(3-Morpholinopropoxy)-4-quinolyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxaMide
N-[3-Fluoro-4-[[6-(methyloxy)-7-[[3-(morpholin-4-yl)propyl]oxy]quinolin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1
N-[3-Fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
N-[3-Fluoro-4-[[6-(methyloxy)-7-[[3-(morpholin-4-yl)propyl]oxy]quinolin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
foretinib N1-{3-fluoro-4-[(6-(Methyloxy)-7-{[3-(4-Morpholinyl)propyl]oxy}-4-quinolinyl)oxy]phenyl}-N1'-(4-fluorophenyl)-1,1-cyclopropanedicarboxaMide
[Molecular Formula]

C34H34F2N4O6
[MDL Number]

MFCD22379992
[MOL File]

849217-64-7.mol
[Molecular Weight]

632.654
Chemical PropertiesBack Directory
[Melting point ]

>98°C (dec.)
[Boiling point ]

828.5±65.0 °C(Predicted)
[density ]

1.372
[storage temp. ]

Sealed in dry,Store in freezer, under -20°C
[solubility ]

DMSO (Slightly), Ethanol (Slightly)
[form ]

Yellow powder.
[pka]

13.14±0.70(Predicted)
[color ]

Pale Yellow to Yellow
[CAS DataBase Reference]

849217-64-7
Hazard InformationBack Directory
[Uses]

XL880 (GSK1363089, EXEL-2880) is an ATP-competitive inhibitor of MET and KDR with IC50 of 0.4 nM and 0.9 nM, respectively.
[Definition]

ChEBI:N1'-[3-fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide is an aromatic ether.
[Clinical Use]

Foretinib has also shown to be effective against ROS1 mutations especially when acquired with crizotinib resistance. A clinical trial investigating the dosing and safety profile of combining foretinib and erlotinib was designed for advanced pretreated NSCLC patients.
[Synthesis]

3-fluoro-{4-[(6-(Methyloxy)-7-{[3-(4-Morpholinyl)propyl]oxy}-4-quinolinyl)oxy]phenyl}aMine

479690-10-3

1-((4-Fluorophenyl)carbamoyl)cyclopropanecarboxylic acid

849217-48-7

Foretinib (GSK1363089)

849217-64-7

Example 3: Preparation of N-[3-fluoro-4-({6-(methoxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1 -dicarboxamide (Compound I, Form B). 3.1: Preparation of compound (I), crystalline form B. [0079] To a dry reactor (Reactor 1) was added 1-(4-fluorophenylcarbamoyl)cyclopropanecarboxylic acid (21.5 kg), THF (76 kg), and N,N-dimethylformamide (DMF, 0.09 kg), and stirred at 20 °C until completely dissolved. The reactor was cooled to about 15 °C and oxalyl chloride (12.7 kg) was slowly added over 38 min while controlling the internal temperature of the reactor below 20 °C. After the addition was complete, the transfer line was flushed with THF (3 kg). After 1 hour of reaction at about 20°C, oxalyl chloride (0.6 kg) and THF (2 kg) were added again to the reactor and the process was repeated once. Subsequently, smaller amounts of oxalyl chloride (0.13 kg) and THF (2 kg) were added a third time. To another dry reactor (reactor 2) was added water (60 L), K2CO3 (11.1 kg), 3-fluoro-4-[(6-methoxy-7-{[3-(4-morpholinyl)propyl]oxy}-4-quinolinyl)oxy]aniline (32.5 kg, see CAS Reg. No. 479690-10-3 and US2004/0242603 ) and THF (177 kg), and the temperature of the reactor contents was adjusted to about 15 °C. The contents of Reactor 1 were slowly added to Reactor 2 while keeping the temperature of Reactor 2 below 20°C. Rinse Reactor 1 with THF (5 kg) and transfer the rinse solution to Reactor 2. The temperature of the contents of Reactor 2 was adjusted to about 20 °C and the reaction was carried out for about 3 hours. Subsequently, 0.8M K2CO3 aqueous solution (171 kg) and isopropyl acetate (119 kg) were added, stirred for 10 minutes, left to stratify, and the lower aqueous phase was discarded. Repeatedly added 0.8M K2CO3 aqueous solution (171kg), mixed and left to stratify, again discarded the aqueous phase. Water (137 kg) was added, mixed and allowed to partition, and the aqueous phase was discarded. Steam-activated powdered activated carbon (Darco G-60, Norit Americas, Inc., 3.4 kg) and isopropyl acetate (3 kg) were added, stirred for about 2.5 hours, and then filtered through a filter containing diatomaceous earth into another reactor (Reactor 3). The reactor 2 was rinsed twice with isopropyl acetate (33 kg each time) and the rinsate was combined with the material in reactor 3 through the above mentioned filter. The material in Reactor 3 was concentrated to about 104 L under vacuum, keeping the temperature below 50°C. Isopropanol (161 kg) was added and again concentrated under vacuum to about 104 L, keeping the temperature below 50°C. Repeatedly added isopropanol (161 kg) and concentrated to about 100 L. Heated the material in Reactor 3 to about 75°C, held for 80 minutes, and then cooled to about 55°C. Heptane (1 kg) containing about 1% isopropanol was added and held at about 55°C for 70 minutes until crystallization was observed. Subsequently, heptane (46 kg) containing about 1% isopropanol was added and the reactor contents were kept at about 55°C for 75 minutes. The reactor contents were cooled to about 20°C over a period of about 5 hours and held at that temperature for about 12 hours. Further cooling to about 5°C and holding for 1 hour. The material in reactor 3 was transferred to a filter drier and rinsed with a mixture of isopropanol (18 kg) and heptane (8 kg). Drying at about 50°C for about 56 hours gave 42.8 kg (89% yield) of compound (I) crystalline form B as an off-white powder.

[in vitro]

In vitro, foretinib blocks activation of MET and VEGFR2-induced signaling pathways. In vivo experiments show a dose-dependent decrease in tumor burden in a lung metastasis experimental model.
[target]

Met
[storage]

Store at -20°C
[References]

[1] qian f1, engst s, yamaguchi k, yu p, won ka, mock l, lou t, tan j, li c, tam d, lougheed j, yakes fm, bentzien f, xu w, zaks t, wooster r,greshock j, joly ah. inhibition of tumor cell growth, invasion, and metastasis by exel-2880 (xl880, gsk1363089), a novel inhibitor of hgf and vegf receptor tyrosine kinases. cancer res. 2009 oct 15;69(20):8009-16. doi: 10.1158/0008-5472.can-08-4889.
Questions And AnswerBack Directory
[Description]

Foretinib (GSK1363089) is an ATP-competitive inhibitor of HGFR and VEGFR, mostly for Met and KDR with IC50 of 0.4 nM and 0.9 nM in cell-free assays. Less potent against Ron, Flt-1/3/4, Kit, PDGFRα/β and Tie-2, and little activity to FGFR1 and EGFR. Phase 2.
Spectrum DetailBack Directory
[Spectrum Detail]

Foretinib (GSK1363089)(849217-64-7)1HNMR
849217-64-7 suppliers list
Company Name: Shanghai Boyle Chemical Co., Ltd.  
Telephone:
Website: www.boylechem.com
Company Name: Chembest Research Laboratories Limited  
Telephone: 021-20908456
Website: www.biochembest.com
Company Name: WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.  
Telephone: 17702719238
Website: http://www.sun-shinechem.com/
Company Name: Chemsky (shanghai) International Co.,Ltd  
Telephone: 021-50135380
Website: www.shchemsky.com
Company Name: Jinan Trio PharmaTech Co., Ltd.  
Telephone: 0531-88811783
Website: www.trio-pharmatech.com
Company Name: QINGDAO CARELONGPHARMATECH CO.,LTD  
Telephone: 053288191853 13061484198
Website: www.chemicalbook.com/showsupplierproductslist15341/0_en.htm
Company Name: Dalian Meilun Biotech Co., Ltd.  
Telephone: 0411-62910999 13889544652
Website: http://www.meilunbio.com/
Company Name: NCE Biomedical Co.,Ltd.  
Telephone: 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Website: www.chemicalbook.com/ShowSupplierProductsList15748/0_EN.htm
Company Name: Nanjing Norris-Pharm Technology Co., Ltd  
Telephone: 13901585132
Website:
Company Name: Haoyuan Chemexpress Co., Ltd.  
Telephone: 021-58950125
Website: http://www.chemexpress.com.cn
Company Name: SYN|thesis med chem P/L  
Telephone: +86-021-50720296
Website: www.synmedchem.cn
Company Name: Shanghai Aladdin Bio-Chem Technology Co.,LTD  
Telephone: 400-6206333 13167063860
Website: www.aladdin-e.com/
Company Name: EnliPharma Technology Co., Ltd  
Telephone: 0551-66399836 18955197623
Website: http://www.enlipharma.com
Company Name: Guangzhou Isun Pharmaceutical Co., Ltd  
Telephone: 020-39119399 18927568969
Website: http://www.isunpharm.com
Company Name: TargetMol Chemicals Inc.  
Telephone: 021-021-33632979 15002134094
Website: https://www.targetmol.cn/
Company Name: CEG Chemical Science&Technology Co., Ltd.  
Telephone: Mobile:13665161512
Website: www.cegchemical.com
Company Name: GIHI CHEMICALS CO.,LTD  
Telephone: 0086-571-86217390
Website: www.gihichem.com
Company Name: Hubei XinyuanShun Chemical Co., Ltd.  
Telephone: 13971561712, 13995564702, 027-50664929
Website: www.chemicalbook.com/ShowSupplierProductsList16209/0_EN.htm
Tags:849217-64-7 Related Product Information
1123889-87-1 1149705-71-4 1251156-08-7 159351-69-6 179324-69-7 849217-68-1 302962-49-8 877399-52-5 763113-22-0